Skip to content

Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MS

Validation of a Fall Prevention Program Among Non-Ambulatory Wheeled Mobility Device Users With Multiple Sclerosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03705364
Acronym
iRoll
Enrollment
120
Registered
2018-10-15
Start date
2018-03-01
Completion date
2020-01-01
Last updated
2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

wheelchair, non-ambulatory

Brief summary

A research study to examine the effectiveness of a fall management program to prevent falls and develop fall recovery strategies for wheeled mobility device users living with Multiple Sclerosis.

Detailed description

Falls are a serious concern for wheelchair and scooter users with Multiple Sclerosis (MS). Approximately 75% of the population reports at least one fall in a 6-month period and nearly half report frequent falls. Falls can result in physical injuries and contribute to activity curtailment. Despite the negative consequences, limited evidenced-based fall prevention programs designed specifically for wheelchair and scooter users with MS exist. Recognizing the threat falls pose to health and well-being and the dearth of fall prevention programs, the purpose of this study to perform a structured process evaluation and examine the feasibility and efficacy of a community-based intervention specifically designed to reduce fall incidence among wheelchair and scooter users with MS. Secondary aims of the intervention are to improve functional mobility skills associated with fall risk (e.g. transfer and wheelchair skills, balance), increase knowledge of fall risk factors, decrease fear of falling and enhance quality of life and community participation.

Interventions

OTHERFall Management program

Comprehensive fall management program that develops strategies for non-ambulatory wheelchair users living with MS to develpo strategies to recover from a fall.

Sponsors

University of Illinois at Urbana-Champaign
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of Multiple Sclerosis 2. \>18 years old 3. Main form of mobility is via a wheeled mobility device (Patient Determined Disease Steps Level 7) 4. Self reported ability to transfer with moderate assistance or less 5. Self-reported fall history (at least 1 fall/12 months)

Exclusion criteria

1. MS exacerbation in the past 30 days 2. Received a score of 10 or above to the Short Blessed Test (attached) 3. Inability to sit upright for at least 1 hour.

Design outcomes

Primary

MeasureTime frameDescription
Reduction in fall incidence44 weeksFall Diary; Construct: to report and track the number of falls experienced; Less number of falls indicates better outcome.

Secondary

MeasureTime frameDescription
Management of Fall44 weeksFall Management Scale (FMS); Construct: to measure the perceived ability to manage risk of falls or actual falls; Scale range: 5 - 45, higher scores indicate lower degree of confidence; Items are summed to get the final score.
Prevention of Fall44 weeksFalls Prevention Strategies Survey (FPSS); Construct: to measure the use of fall prevention strategies; Scale range: 0 - 22, higher scores reflect more regular use of more fall prevention strategies; Never do: 0, Do sometimes: 1, Do regularly: 2; Items are summed to get the final score.
Prevention and Management of Fall44 weeksFalls Prevention and Management Questionnaire (FPMQ); Construct: to measure the ability to prevent and manage falls; Scale range: 0 - 48, higher scores indicate higher ability to prevent and manage falls; Items are scored from 0 (strongly disagree) to 4 (strongly agree); Items are summed to get the final score.

Countries

United States

Contacts

Primary ContactEmily Pike, MPH
dpqoluiuc@outlook.com217-244-7006

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026